JP6957452B2 - 腸の感染症及び炎症の治療及び予防のための組成物及び方法 - Google Patents

腸の感染症及び炎症の治療及び予防のための組成物及び方法 Download PDF

Info

Publication number
JP6957452B2
JP6957452B2 JP2018510510A JP2018510510A JP6957452B2 JP 6957452 B2 JP6957452 B2 JP 6957452B2 JP 2018510510 A JP2018510510 A JP 2018510510A JP 2018510510 A JP2018510510 A JP 2018510510A JP 6957452 B2 JP6957452 B2 JP 6957452B2
Authority
JP
Japan
Prior art keywords
composition
lmg
plantalum
fiber
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018510510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526370A5 (enExample
JP2018526370A (ja
Inventor
アガイベイクーラヴァサニ、シャラム
ノウリ、メールナツ
Original Assignee
イムネバイオテック・メディカル・スウェーデン・エービー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イムネバイオテック・メディカル・スウェーデン・エービー filed Critical イムネバイオテック・メディカル・スウェーデン・エービー
Publication of JP2018526370A publication Critical patent/JP2018526370A/ja
Publication of JP2018526370A5 publication Critical patent/JP2018526370A5/ja
Application granted granted Critical
Publication of JP6957452B2 publication Critical patent/JP6957452B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/24—Lactobacillus brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2018510510A 2015-08-25 2016-08-23 腸の感染症及び炎症の治療及び予防のための組成物及び方法 Active JP6957452B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1551099 2015-08-25
SE1551099-3 2015-08-25
PCT/SE2016/050787 WO2017034460A1 (en) 2015-08-25 2016-08-23 Composition and method for treatment and prophylaxis of intestinal infection and inflammation

Publications (3)

Publication Number Publication Date
JP2018526370A JP2018526370A (ja) 2018-09-13
JP2018526370A5 JP2018526370A5 (enExample) 2019-09-26
JP6957452B2 true JP6957452B2 (ja) 2021-11-02

Family

ID=58100550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018510510A Active JP6957452B2 (ja) 2015-08-25 2016-08-23 腸の感染症及び炎症の治療及び予防のための組成物及び方法

Country Status (16)

Country Link
US (1) US10632159B2 (enExample)
EP (1) EP3341001B1 (enExample)
JP (1) JP6957452B2 (enExample)
KR (1) KR102656709B1 (enExample)
CN (1) CN108135948B (enExample)
AU (2) AU2016312870B2 (enExample)
BR (1) BR112018003123B1 (enExample)
CA (1) CA2995071A1 (enExample)
DK (1) DK3341001T3 (enExample)
ES (1) ES2909430T3 (enExample)
IL (1) IL257568A (enExample)
MX (1) MX395262B (enExample)
PL (1) PL3341001T3 (enExample)
RU (1) RU2738803C2 (enExample)
WO (1) WO2017034460A1 (enExample)
ZA (1) ZA201801266B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7015674B2 (ja) * 2017-10-27 2022-02-15 日清食品ホールディングス株式会社 制御性ｔ細胞の分化誘導剤及び分化誘導方法
JP2019187251A (ja) * 2018-04-19 2019-10-31 国立研究開発法人農業・食品産業技術総合研究機構 発酵物の製造方法及び発酵物
WO2020180037A1 (ko) * 2019-03-04 2020-09-10 경북대학교 산학협력단 인간 장내 미생물 군집 모사 배양용 조성물, 혐기 배양 체계를 이용한 인간 장내 미생물 군집의 모사 배양 방법, 이에 의해 제조된 미생물 제제 및 이의 용도
CN110129221B (zh) * 2019-05-06 2022-05-17 福建晋江国食文化传媒有限公司 乳酸菌hwn19菌株及其应用
CN111358798A (zh) * 2020-03-13 2020-07-03 暨南大学 低聚糖阿魏酸酯的新应用
WO2022039561A1 (ko) * 2020-08-21 2022-02-24 서울대학교산학협력단 클로스트리디움 디피실리 감염의 치료 또는 예방용 조성물
KR102488609B1 (ko) * 2020-09-24 2023-01-12 국립낙동강생물자원관 장내 유해세균 억제 기능을 가진 락토바실러스 파라부크네리 nsmj16 (kacc81129bp) 및 락토바실러스 브레비스 nsmj23(kacc81130bp)
KR102363975B1 (ko) * 2020-12-11 2022-02-17 주식회사 바이오뱅크힐링 락토바실러스 플란타룸 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
US12433922B2 (en) * 2021-09-22 2025-10-07 Asahi Biocycle Co., Ltd. Composition for prophylaxis of enteritis in avian comprising lactobacillus plantarum strain
CN115466699B (zh) * 2022-09-28 2023-03-31 成都大熊猫繁育研究基地 熊猫源唾液乳杆菌及在治疗或预防炎症性肠病中的应用
CN116286476B (zh) * 2023-02-06 2025-09-12 华南理工大学 一株短乳杆菌及其抑菌优化培养方法和应用
CN116875520B (zh) * 2023-07-12 2024-06-14 吉林农业大学 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用
KR102628942B1 (ko) * 2023-08-08 2024-01-26 주식회사 바이오뱅크힐링 레비락토바실러스 브레비스 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
WO2025033636A1 (ko) * 2023-08-08 2025-02-13 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN117467568B (zh) * 2023-09-22 2025-02-14 福建省农业科学院畜牧兽医研究所 一株短乳杆菌zg-7及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
JP5363811B2 (ja) * 2005-09-28 2013-12-11 ノルディスク リバランス アクティーゼルスカブ 治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
WO2008064521A1 (en) * 2006-11-30 2008-06-05 Pharmapep Research & Development (Shenzhen) Co., Ltd. Lactobacillus fermentum cms-h002 and use thereof
CN101951922B (zh) * 2007-10-11 2013-03-20 菲尔菲德食品有限公司 治疗小肠感染的包含寡聚糖及不溶性多孔材料的制剂
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
JP2014166972A (ja) * 2013-02-28 2014-09-11 Kagome Co Ltd 腸炎抑制剤及び飲食品
CN104611275B (zh) * 2015-02-11 2017-10-17 成都与康科技有限公司 植物乳杆菌ucn‑11菌株及其组合物和应用

Also Published As

Publication number Publication date
RU2018105964A3 (enExample) 2020-01-28
MX2018002093A (es) 2018-09-12
PL3341001T3 (pl) 2022-07-04
US20180243353A1 (en) 2018-08-30
AU2023201997A1 (en) 2023-05-04
AU2016312870A1 (en) 2018-03-08
BR112018003123B1 (pt) 2021-09-28
ES2909430T3 (es) 2022-05-06
EP3341001B1 (en) 2021-12-29
ZA201801266B (en) 2019-06-26
CN108135948A (zh) 2018-06-08
CN108135948B (zh) 2022-04-12
RU2018105964A (ru) 2019-09-26
BR112018003123A2 (pt) 2018-09-25
EP3341001A4 (en) 2019-07-03
KR20180041144A (ko) 2018-04-23
CA2995071A1 (en) 2017-03-02
DK3341001T3 (da) 2022-03-21
MX395262B (es) 2025-03-25
EP3341001A1 (en) 2018-07-04
WO2017034460A1 (en) 2017-03-02
IL257568A (en) 2018-04-30
US10632159B2 (en) 2020-04-28
KR102656709B1 (ko) 2024-04-09
JP2018526370A (ja) 2018-09-13
AU2016312870B2 (en) 2023-04-20
RU2738803C2 (ru) 2020-12-17

Similar Documents

Publication Publication Date Title
JP6957452B2 (ja) 腸の感染症及び炎症の治療及び予防のための組成物及び方法
JP5889191B2 (ja) コレステロール低下剤としてのラクトバチルス・プランタルム菌株
JP2024129008A (ja) 相乗的細菌組成物並びにその生成及び使用の方法
US10638784B2 (en) Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof
KR101768678B1 (ko) 한국 장수마을에서 개발된 건강기능성이 우수한 비피도박테리움 롱검 아종 인판티스 bi9988
KR101452234B1 (ko) 장수마을 성인으로부터 분리한 배변활동에 도움을 주는 신규한 유산균 락토바실러스 퍼멘텀
KR20060056991A (ko) 박테리아 균주, 이를 포함하는 조성물 및 이들의 용도
JP2005508617A (ja) プロバイオティックビフィドバクテリウム株類
JP2006522766A (ja) シンビオティックな組み合わせ
JP2013517784A (ja) 腸炎症の処置における使用のためのプロバイオティクス組成物
TW202325835A (zh) 使用乳酸菌菌株組合來提升腸胃道屏障功能
EP2220210B1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
TWI337079B (en) Compositions comprising oligosaccharides
KR101488770B1 (ko) 한국 장수마을의 장수인에게서 개발한 락토바실러스 퍼멘텀 ｐｌ９０３６
Onyenweaku et al. Research Article Health Benefits of Probiotics
JP2008502606A (ja) 乳酸菌及び下痢の予防におけるそれらの使用
Pande et al. Prospectus of probiotics in modern age diseases
JP7267536B2 (ja) 乳酸醗酵ニンジンの製造方法
TWI842161B (zh) 益生菌組合及其用於腸胃道保健或調節免疫力的用途
JP7408070B2 (ja) ビフィドバクテリウム・ビフィダムを含む免疫力増強または改善用組成物
TJANDRAWINATA et al. Characterization of in vitro antagonistic activity of Lactobacillus helveticus DLBSA201 and DLBSA202 against Escherichia coli 0157: H7
CN117918527A (zh) 益生菌组合及其用于肠胃道保健或提升免疫力的用途
Fiore Overall Assessment of a Model Probiotic Bacterium: from Gut Colonization to Clinical Efficacy
van den Broek In vitro and in vivo probiotic potential of Lactobacillus spp. for otitis media
KR20230152489A (ko) 영유아 및 임산부의 유해균에 대한 장건강 개선용 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180314

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20180314

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190816

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210820

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210907

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211006

R150 Certificate of patent or registration of utility model

Ref document number: 6957452

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250